Regeneron’s COVID-19 Treatment Gets Emergency Approval from FDA

New York Post

The U.S. Food and Drug Administration has given the green light for emergency use of Regeneron’s COVID-19 antibody drug — the same treatment given to President Trump.

The treatment is aimed at those with mild cases of COVID-19, and not for those hospitalized as a result of the virus, the FDA said.

The treatment works by mimicking the body’s own immune system to prevent the infected from become severely ill.

Read More at the New York Post

Be the first to comment!

The comment must be no longer than 400 characters 0/400